Guowei W. Shi
No. 801, Heqing Road
Minhang, 200240, China
Minhang, 200240, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 43 publications
Targeting USP42 induces DNA damage and inhibits cell growth in prostate cancer.
Journal: Frontiers in molecular biosciences
Published: June 13, 2025
Elevated VRK1 levels after androgen deprivation therapy promote prostate cancer progression by upregulating YAP1 expression.
Journal: Journal of cancer research and clinical oncology
Published: February 08, 2025
Efficacy and safety of non-invasive low-frequency tibial nerve stimulator in overactive bladder.
Journal: European journal of medical research
Published: October 14, 2024
USP54 is a potential therapeutic target in castration-resistant prostate cancer.
Journal: BMC urology
Published: November 20, 2023
Identification of molecular subtypes and a prognostic signature based on chromatin regulators related genes in prostate cancer.
Journal: Frontiers in genetics
Published: November 29, 2022
Proxalutamide in metastatic castration-resistant prostate cancer: Primary analysis of a multicenter, randomized, open-label, phase 2 trial.
Journal: International journal of cancer
Published: November 09, 2022
Re: Mathew D. Sorensen, Jonathan D. Harper, Michael S. Borofsky, et al. Removal of Small, Asymptomatic Kidney Stones and Incidence of Relapse. N Engl J Med 2022;387:506-13.
Journal: European urology
Published: October 31, 2022
Fibrinogen/poly(l-lactide-co-caprolactone) copolymer scaffold: A potent adhesive material for urethral tissue regeneration in urethral injury treatment.
Journal: Regenerative therapy
Published: July 04, 2022
Endoscopic balloon cryoablation plus transurethral resection for bladder cancer: A phase 2, multicenter, randomized, controlled trial.
Journal: Cancer
Published: June 20, 2022
Study of female pelvic floor muscle in overactive bladder based on MRI 3D reconstruction.
Journal: BMC urology
Published: May 19, 2022
Hengli® Chinese Botulinum Toxin Type A for Treatment of Patients With Overactive Bladder: A Multicenter, Prospective, Randomized, Double-Blind, Placebo-Controlled Trial.
Journal: Frontiers in pharmacology
Published: December 22, 2021
Efficacy of Yougui pill combined with Buzhong Yiqi decoction in alleviating the sexual dysfunction in female rats through modulation of the gut microbiota.
Journal: Pharmaceutical biology
Published: December 14, 2021
Last Updated: 09/26/2026